Role of diet in hyperuricemia and gout.
Danve A, Sehra ST, Neogi T.
Best Pract Res Clin Rheumatol. 2021 Dec;35(4):101723. doi: 10.1016/j.berh.2021.101723. Epub 2021 Nov 19.
The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
Eckenstaler R, Benndorf RA.
Int J Mol Sci. 2021 Jun 22;22(13):6678. doi: 10.3390/ijms22136678.
The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics.
Wu X, You C.
PeerJ. 2023 Jan 6;11:e14554. doi: 10.7717/peerj.14554. eCollection 2023.
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors.
Dehlin M, Jacobsson L, Roddy E.
Nat Rev Rheumatol. 2020 Jul;16(7):380-390. doi: 10.1038/s41584-020-0441-1. Epub 2020 Jun 15.
Circulating microRNA alternations in primary hyperuricemia and gout.
Bohatá J, Horváthová V, Pavlíková M, Stibůrková B.
Arthritis Res Ther. 2021 Jul 10;23(1):186. doi: 10.1186/s13075-021-02569-w.
Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements.
Li Q, Li X, Wang J, Liu H, Kwong JS, Chen H, Li L, Chung SC, Shah A, Chen Y, An Z, Sun X, Hemingway H, Tian H, Li S.
BMJ Open. 2019 Aug 24;9(8):e026677. doi: 10.1136/bmjopen-2018-026677.
Primary prevention in rheumatology: the importance of hyperuricemia.
Vázquez-Mellado J, Alvarez Hernández E, Burgos-Vargas R.
Best Pract Res Clin Rheumatol. 2004 Apr;18(2):111-24. doi: 10.1016/j.berh.2004.01.001.
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y; FEATHER Study Investigators.
Am J Kidney Dis. 2018 Dec;72(6):798-810. doi: 10.1053/j.ajkd.2018.06.028. Epub 2018 Sep 1.
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review.
Terkeltaub R.
Drugs. 2023 Nov;83(16):1501-1521. doi: 10.1007/s40265-023-01944-y. Epub 2023 Oct 11.
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N.
N Engl J Med. 2005 Dec 8;353(23):2450-61. doi: 10.1056/NEJMoa050373.
